We are live on ! Find out more
YC

Yarbrough Capital Portfolio holdings

AUM $2.85B
1-Year Est. Return 36.22%
This Fund
S&P 500
This Quarter Est. Return
+14.58%
1 Year Est. Return
+36.22%
3 Year Est. Return
+146.68%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.91B
AUM Growth
+$207M
Cap. Flow
-$25.4M
Cap. Flow %
-1.33%
Top 10 Hldgs %
65.71%
Holding
213
New
9
Increased
10
Reduced
10
Closed
10

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.16M
2
ALGN icon
Align Technology
ALGN
+$408K
3
NOVT icon
Novanta
NOVT
+$375K
4
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
+$374K
5
ALL icon
Allstate
ALL
+$358K

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$10.3M
2
NVDA icon
NVIDIA
NVDA
+$6.34M
3
AAPL icon
Apple
AAPL
+$6.21M
4
CWB icon
State Street SPDR Bloomberg Convertible Securities ETF
CWB
+$4.84M
5
LIT icon
Global X Lithium & Battery Tech ETF
LIT
+$2.65M

Sector Composition

Rank Sector Weight
1 Technology 40.37%
2 Communication Services 15.64%
3 Consumer Discretionary 8.94%
4 Financials 4.85%
5 Energy 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABNB icon
176
Airbnb
ABNB
$89.4B
$328K 0.02%
2,406
– –
BJ icon
177
BJs Wholesale Club
BJ
$12.4B
$321K 0.02%
4,808
– –
INCY icon
178
Incyte
INCY
$24B
$313K 0.02%
4,990
– –
IT icon
179
Gartner
IT
$10.1B
$305K 0.02%
+676
New +$270K
PLMR icon
180
Palomar
PLMR
$3.62B
$297K 0.02%
5,351
– –
CCRN
181
DELISTED
Cross Country Healthcare
CCRN
$293K 0.02%
12,951
– –
GOGO icon
182
Gogo Inc
GOGO
$606M
$289K 0.02%
28,526
– –
EW icon
183
Edwards Lifesciences
EW
$51.1B
$288K 0.02%
3,776
– –
THS
184
DELISTED
Treehouse Foods
THS
$286K 0.02%
6,901
– –
SITE icon
185
SiteOne Landscape Supply
SITE
$4.33B
$279K 0.01%
1,716
– –
DHR icon
186
Danaher
DHR
$139B
$272K 0.01%
1,175
-150
-11% -$31.9K
SRPT icon
187
Sarepta Therapeutics
SRPT
$1.68B
$269K 0.01%
2,790
– –
TYL icon
188
Tyler Technologies
TYL
$12.5B
$253K 0.01%
605
– –
RSPH icon
189
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$774M
$252K 0.01%
8,470
– –
IRDM icon
190
Iridium Communications
IRDM
$5.12B
$251K 0.01%
6,105
– –
JNJ icon
191
Johnson & Johnson
JNJ
$613B
$241K 0.01%
1,538
– –
DOCS icon
192
Doximity
DOCS
$3.95B
$240K 0.01%
+8,572
New +$202K
CTLT
193
DELISTED
CATALENT, INC.
CTLT
$237K 0.01%
5,276
– –
CERT icon
194
Certara
CERT
$1.27B
$228K 0.01%
12,954
– –
AZEK
195
DELISTED
The AZEK Co
AZEK
$225K 0.01%
+5,875
New +$183K
STKL
196
DELISTED
SunOpta
STKL
$219K 0.01%
40,044
– –
EB
197
DELISTED
Eventbrite
EB
$213K 0.01%
25,459
– –
TMDX icon
198
Transmedics
TMDX
$2.82B
$201K 0.01%
+2,541
New +$153K
PTLO icon
199
Portillo's
PTLO
$329M
$172K 0.01%
10,770
-5,385
-33% -$83.2K
MRVI icon
200
Maravai LifeSciences
MRVI
$947M
$162K 0.01%
24,731
– –
5 6 7
8
9

Similar funds

WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
CAM
Crake Asset Management London, United Kingdom $2.86B AUM 16.35% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
CCM
Chilton Capital Management Houston, Texas $2.87B AUM 25.44% 1-Year Est. Return

Yarbrough Capital's Q4 2023 Portfolio in Review

As of Q4 2023, Yarbrough Capital held 213 positions worth $1.91B, up 12% from $1.7B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Yarbrough Capital's Q4 2023 filing shows 9 new, 10 increased, 10 reduced and 10 closed positions. Its largest new stake was Fusion Pharmaceuticals Inc. Common Shares: 76,872 shares worth $739K. The largest sale was Activision Blizzard, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 40% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Yarbrough Capital's largest Q4 2023 buy was Fusion Pharmaceuticals Inc. Common Shares: 76,872 shares worth $739K.
  • Yarbrough Capital added most to Alibaba in Q4 2023, an estimated $5.16M increase.
  • Yarbrough Capital's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $6.34M.
  • Yarbrough Capital fully exited Activision Blizzard in Q4 2023, selling an estimated $10.3M.
  • Yarbrough Capital's ten largest holdings make up 66% of its $1.91B portfolio in Q4 2023.
  • Yarbrough Capital opened 9 new positions and closed 10 in Q4 2023.
  • Yarbrough Capital's portfolio value rose 12% quarter-over-quarter to $1.91B.

Based on Yarbrough Capital's 13F filing for Q4 2023, filed 12 Jan 2024.